R. Andrew Sewell

2.6k total citations
36 papers, 1.8k citations indexed

About

R. Andrew Sewell is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, R. Andrew Sewell has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 14 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in R. Andrew Sewell's work include Cannabis and Cannabinoid Research (14 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). R. Andrew Sewell is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). R. Andrew Sewell collaborates with scholars based in United States, Canada and Australia. R. Andrew Sewell's co-authors include Deepak Cyril D’Souza, Mehmet Sofuoglu, Mohini Ranganathan, James Poling, John H. Halpern, Brian Pittman, Harrison G. Pope, Patrick D. Skosnik, Ashley M. Schnakenberg Martin and Emmanuelle A. D. Schindler and has published in prestigious journals such as Neurology, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

R. Andrew Sewell

36 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Andrew Sewell United States 22 752 727 546 279 278 36 1.8k
Tomáš Páleníček Czechia 25 600 0.8× 1.2k 1.6× 1.0k 1.9× 299 1.1× 446 1.6× 84 2.4k
Patrick D. Skosnik United States 31 1.1k 1.5× 1.0k 1.4× 376 0.7× 355 1.3× 95 0.3× 63 2.5k
Eef L. Theunissen Netherlands 32 1.7k 2.2× 914 1.3× 923 1.7× 223 0.8× 347 1.2× 94 3.0k
Matthew J. Baggott United States 20 377 0.5× 475 0.7× 632 1.2× 110 0.4× 96 0.3× 36 1.4k
José Alexandre S. Crippa Brazil 22 2.1k 2.8× 859 1.2× 616 1.1× 370 1.3× 75 0.3× 45 3.0k
Valerie H. Curran United Kingdom 10 639 0.8× 765 1.1× 1.1k 2.0× 93 0.3× 600 2.2× 15 1.9k
Will Lawn United Kingdom 20 587 0.8× 472 0.6× 482 0.9× 110 0.4× 118 0.4× 60 1.2k
J.A.S. Crippa Brazil 19 930 1.2× 548 0.8× 278 0.5× 293 1.1× 80 0.3× 31 1.6k
David Nutt United Kingdom 29 348 0.5× 1.3k 1.8× 342 0.6× 307 1.1× 102 0.4× 72 2.5k
Samuel T. Wilkinson United States 29 2.3k 3.1× 584 0.8× 630 1.2× 950 3.4× 110 0.4× 89 3.3k

Countries citing papers authored by R. Andrew Sewell

Since Specialization
Citations

This map shows the geographic impact of R. Andrew Sewell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Andrew Sewell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Andrew Sewell more than expected).

Fields of papers citing papers by R. Andrew Sewell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Andrew Sewell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Andrew Sewell. The network helps show where R. Andrew Sewell may publish in the future.

Co-authorship network of co-authors of R. Andrew Sewell

This figure shows the co-authorship network connecting the top 25 collaborators of R. Andrew Sewell. A scholar is included among the top collaborators of R. Andrew Sewell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Andrew Sewell. R. Andrew Sewell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schindler, Emmanuelle A. D., R. Andrew Sewell, Christopher Gottschalk, et al.. (2020). Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. Neurotherapeutics. 18(1). 534–543. 90 indexed citations
2.
Boggs, Douglas L., Toral Surti, Irina Esterlis, et al.. (2017). Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the “self-medication” hypothesis in schizophrenia. Schizophrenia Research. 194. 62–69. 29 indexed citations
3.
Ranganathan, Mohini, Rajiv Radhakrishnan, Peter H. Addy, et al.. (2017). Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 79(Pt B). 176–183. 31 indexed citations
4.
Radhakrishnan, Rajiv, Patrick D. Skosnik, Jose Cortes-Briones, et al.. (2015). GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC. Neuropsychopharmacology. 40(8). 2047–2056. 25 indexed citations
5.
Schindler, Emmanuelle A. D., et al.. (2015). Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey. Journal of Psychoactive Drugs. 47(5). 372–381. 73 indexed citations
6.
Cortes-Briones, Jose, Patrick D. Skosnik, Daniel H. Mathalon, et al.. (2015). Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Neuropsychopharmacology. 40(9). 2124–2134. 52 indexed citations
7.
Ranganathan, Mohini, R. Andrew Sewell, Michelle Carbuto, et al.. (2014). Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism. Psychopharmacology. 231(12). 2385–2393. 7 indexed citations
8.
Cortes-Briones, Jose, John D. Cahill, Mohini Ranganathan, et al.. (2014). Testing differences in the activity of event-related potential sources: Important implications for clinical researchers. Clinical Neurophysiology. 126(1). 215–218. 2 indexed citations
9.
D’Souza, Deepak Cyril, Daniel J. Fridberg, Patrick D. Skosnik, et al.. (2012). Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans. Neuropsychopharmacology. 37(7). 1632–1646. 84 indexed citations
10.
Esterlis, Irina, Jonas Hannestad, Frédéric Y. Bois, et al.. (2012). Imaging Changes in Synaptic Acetylcholine Availability in Living Human Subjects. Journal of Nuclear Medicine. 54(1). 78–82. 32 indexed citations
11.
Ranganathan, Mohini, Ashley M. Schnakenberg Martin, Patrick D. Skosnik, et al.. (2012). Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans. Biological Psychiatry. 72(10). 871–879. 101 indexed citations
12.
Ranganathan, Mohini, Michelle Carbuto, Gabriel Braley, et al.. (2012). Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The International Journal of Neuropsychopharmacology. 15(9). 1251–1264. 21 indexed citations
13.
Carbuto, Michelle, R. Andrew Sewell, Ashley Williams, et al.. (2011). The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories. Psychopharmacology. 219(3). 885–896. 25 indexed citations
14.
Johnson, Matthew W., R. Andrew Sewell, & Roland R. Griffiths. (2011). Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug and Alcohol Dependence. 123(1-3). 132–140. 62 indexed citations
15.
Sewell, R. Andrew, Edward Perry, Laurence P. Karper, et al.. (2010). Clinical significance of neurological soft signs in schizophrenia: Factor analysis of the Neurological Evaluation Scale. Schizophrenia Research. 124(1-3). 1–12. 26 indexed citations
16.
Sewell, R. Andrew, et al.. (2010). Efeitos comportamentais, cognitivos e psicofisiológicos dos canabinoides: relevância para a psicose e a esquizofrenia. Brazilian Journal of Psychiatry. 32(suppl 1). 515–530. 31 indexed citations
17.
Sewell, R. Andrew, James Poling, & Mehmet Sofuoglu. (2009). The Effect of Cannabis Compared with Alcohol on Driving. American Journal on Addictions. 18(3). 185–193. 243 indexed citations
18.
D’Souza, Deepak Cyril, R. Andrew Sewell, & Mohini Ranganathan. (2009). Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry and Clinical Neuroscience. 259(7). 413–431. 191 indexed citations
19.
Davis, Glen P., R. Andrew Sewell, Boaz Levy, Bruce H. Price, & Miles G. Cunningham. (2009). An Atypical Presentation of Anton Syndrome in a Patient with Preserved Cognition Despite Multiple Cerebral Infarcts: A Case Report. CNS Spectrums. 14(1). 15–18. 5 indexed citations
20.
Sewell, R. Andrew, et al.. (2008). Cluster headache associated with moyamoya. The Journal of Headache and Pain. 10(1). 65–67. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026